Acute pancreatitis has been reported with incretin-based therapies, and patients with a history of pancreatitis may be at increased risk for recurrence
Blandizzi C, Viscomi GC, Marzo A, Scarpignato C
Suzanne Craft, Mitzi Gonzales, James Kirkland, Nicolas Musi, Ronald Petersen, Sudha Seshadri and Tamara Tchkonia for their significant contributions to the Phase 2 study design of SToMP-AD, and their ongoing collaborative support as co-investigators on the trial (NCT04685590)
Over about 84 weeks, people taking CagriSema lost around 23% of their body weight, while those on Zepbound lost about 25.5% at its highest dose
CJC-1295 DAC is long-acting because the DAC structure allows albumin binding
Having a dependable source for sterile water with a preservative has made a huge difference in my daily lab tasks